Trial intelligence / Profile preview

CBD Occlusal Appliance for TMD

NCT04775030Phase 3Unknown

Sponsor
Medical University of Silesia
Start
Jan 2021
Primary completion
Jan 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of cannabidiol in temporomandibular joint disorders (TMD), sponsored by Medical University of Silesia. Status: unknown.

02

Drugs

cannabidiol
03

Conditions

temporomandibular joint disorders (TMD)

Beyond the preview

Go deeper on NCT04775030.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04775030.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call